Showing results (51-60 of 593) with videos related to
Sort By:
Pageof 60
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.Blood|April 15, 1991
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combinationR M Lemoli, C Gasparetto, D A Scheinberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Myeloablative combination chemotherapy without total body irradiation for neuroblastomaB H Kushner, R J O'Reilly, L R Mandell, et al.Bone Marrow Transplantation|April 1, 1994
Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxinsR M Lemoli, P L Tazzari, A Fortuna, et al.Cancer|August 15, 1980
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's diseaseS C Gulati, R Mertelsmann, T Gee, et al.Stem Cells (Dayton, Ohio)|July 1, 1994
Economic analyses of clinical trials in cancer: are they helpful to policy makers?C L Bennett, J L Armitage, S LeSage, et al.Leukemia & Lymphoma|June 1, 1993
Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantationL KumarCancer Investigation|January 1, 1989
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamideS C Gulati, J H Kwon, B Kushner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Leukemia: management of relapse after allogeneic bone marrow transplantationL KumarCancer|April 1, 1991
Extracranial primitive neuroectodermal tumors. The Memorial Sloan-Kettering Cancer Center experienceB H Kushner, S I Hajdu, S C Gulati, et al.Pageof 60